We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Sees 28 Percent Increase in Orphan Drug Applications in 2016
EMA Sees 28 Percent Increase in Orphan Drug Applications in 2016
The European Medicines Agency saw a 28 percent increase in the number of applications for orphan product designations in 2016 compared to the previous year.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor